Intranasal Delivery of Botulinum Neurotoxin A Protects against Hippocampal Neuron Death in the Lithium-Pilocarpine Rat Model
Botulinum neurotoxins (BoNTs) block the release of a series of neurotransmitters, which are pivotal for neuron action. Intrahippocampal administration of BoNTs inhibits glutamate release, protects neurons against cell death, and attenuates epileptic seizures. Compared with intrahippocampal administration, intranasal delivery is less invasive and more practical for chronic drug administration. To assess whether intranasal administration is feasible, we examined the role of botulinum neurotoxin A (BoNT/A) in hippocampal neuronal injury after status epilepticus (SE) induced by pilocarpine. Our data showed BoNT/A could bypass the blood–brain barrier (BBB) and entered the olfactory bulb and hippocampal neurons. In addition, SE could result in up-regulation of pro-apoptotic proteins (Caspase-3, Bax), down-regulation of anti-apoptotic protein Bcl-2 and neuronal death in hippocampus. BoNT/A could suppress the expression of Caspase-3 and Bax, attenuate the decrease of Bcl-2, and inhibit hippocampal neuron death induced by SE. Meanwhile, there was no significant difference in cognitive behavior between the BoNT/A-pretreated rats and normal rats. Thus, we provided a more convenient and less invasive route for taking advantage of BoNT/A in the field of anti-epilepsy.
KeywordsBotulinum Neurotoxin A Intranasal delivery Epilepsy Olfactory nerve pathway Apoptosis
This work was supported by the National Natural Science Foundation of China (Grant No. 81771397).
Compliance with Ethical Standards
Conflict of interest
No conflicts of interest
- 9.Verderio C, Pozzi D, Pravettoni E, Inverardi F, Schenk U, Coco S, Proux-Gillardeaux V, Galli T, Rossetto O, Frassoni C, Matteoli M (2004) SNAP-25 modulation of calcium dynamics underlies differences in GABAergic and glutamatergic responsiveness to depolarization. Neuron 41:599–610CrossRefPubMedGoogle Scholar
- 21.Liu HT, Chen SH, Chancellor MB, Kuo HC (2015) Presence of cleaved synaptosomal-associated protein-25 and decrease of purinergic receptors P2×3 in the bladder urothelium influence efficacy of botulinum toxin treatment for overactive bladder syndrome. PLoS ONE 10:e0134803CrossRefPubMedPubMedCentralGoogle Scholar
- 26.Tao H, Zhao J, Liu T, Cai Y, Zhou X, Xing H, Wang Y, Yin M, Zhong W, Liu Z, Li K, Zhao B, Zhou H, Cui L (2017) Intranasal delivery of miR-146a mimics delayed seizure onset in the lithium-pilocarpine mouse model. Mediat Inflamm 2017:6512620Google Scholar